Gascon-Barré M, D'Amour P, Dufresne L, Perreault J P
Ann Nutr Metab. 1985;29(5):289-96. doi: 10.1159/000176984.
Serum 25-hydroxyvitamin D [25(OH)D], 24,25-dihydroxyvitamin D [24,25(OH)2D] and 1,25-dihydroxyvitamin D [1,25(OH)2D] were studied in renal stone formers while on a diet containing 1,000 or 300 mg calcium per day. The patients were divided into four groups and identified as (a) normocalciuric (NSF), (b) absorptive hypercalciuric (AH), (c) renal hypercalciuric (RH) and (d) as having primary hyperparathyroidism (PHP). The results indicate that, on the 1,000-mg Ca diet, the mean 25(OH)D, 24,25(OH)2D and 1,25(OH)2D concentrations were within the normal range in all groups of patients. On the low-calcium diet, 25(OH)D concentrations decreased significantly in patients with AH and RH while 24,25(OH)2D concentrations were not affected by the low-calcium diet. 1,25(OH)2D concentrations increased significantly during dietary calcium restriction in all groups of patients. When the relationship obtained on each diet between the circulating 25(OH)D concentrations and the 25(OH)D/1,25(OH)2D concentration ratio was compared, it suggested that the increase in the 1,25(OH)2D concentrations during dietary calcium restriction may have been due to an increase in the capacity of the 25(OH)D-1 alpha-hydroxylase, or to an increase in the circulating half-life of the hormone. These results indicate that renal stone formers are able to adapt themselves to dietary calcium restriction as shown by highly significant increases in the circulating 1,25(OH)2D concentrations while on a low-calcium diet. Moreover, the increase in the circulating 1,25(OH)2D concentrations did not happen at the expense of the 24,25(OH)2D production in any of the groups of patients studied.
对肾结石患者在每日摄入1000毫克或300毫克钙的饮食条件下,研究了血清25-羟基维生素D [25(OH)D]、24,25-二羟基维生素D [24,25(OH)₂D] 和1,25-二羟基维生素D [1,25(OH)₂D]。患者被分为四组,分别为 (a) 正常钙尿症组 (NSF)、(b) 吸收性高钙尿症组 (AH)、(c) 肾性高钙尿症组 (RH) 和 (d) 原发性甲状旁腺功能亢进组 (PHP)。结果表明,在摄入1000毫克钙的饮食时,所有患者组的平均25(OH)D、24,25(OH)₂D和1,25(OH)₂D浓度均在正常范围内。在低钙饮食时,AH组和RH组患者的25(OH)D浓度显著下降,而24,25(OH)₂D浓度不受低钙饮食影响。在所有患者组中,饮食钙限制期间1,25(OH)₂D浓度显著升高。当比较每种饮食条件下循环25(OH)D浓度与25(OH)D/1,25(OH)₂D浓度比值之间的关系时,提示饮食钙限制期间1,25(OH)₂D浓度升高可能是由于25(OH)D-1α-羟化酶活性增加,或激素循环半衰期延长。这些结果表明,肾结石患者能够适应饮食钙限制,如在低钙饮食时循环1,25(OH)₂D浓度显著升高所示。此外,在所研究的任何患者组中,循环1,25(OH)₂D浓度的升高均未以牺牲24,25(OH)₂D的产生为代价。